Association of polymorphisms in the chemokine receptor CX3CR1 gene with coronary artery disease

Cytokine

Volumn 47, Issue 3, 2009, Pages 224-227

  Matzhold, Eva M ^a   Trummer, Olivia ^a   Grünbacher, Gerda ^a   Zulus, Barbara ^a   Boehm, Bernhard O ^b   März, Winfried ^a,c   Renner, Wilfried ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c SYNLAB ACADEMY   (Germany)

Author keywords

Coronary artery disease; Genetics; Myocardial infarction

Indexed keywords

C REACTIVE PROTEIN; CHEMOKINE RECEPTOR CX3CR1;

ADULT; AGE; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GENDER; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ALLELES; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CHEMOKINE;

EID: 68949162040     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.06.010     Document Type: Article

References (32)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 314 (1986) 488-500
3. Combadiere C., Potteaux S., Gao J.L., Esposito B., Casanova S., Lee E.J., et al. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 107 (2003) 1009-1016
4. Greaves D.R., Hakkinen T., Lucas A.D., Liddiard K., Jones E., Quinn C.M., et al. Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 21 (2001) 923-929
5. Lesnik P., Haskell C.A., and Charo I.F. Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J Clin Invest 111 (2003) 333-340
6. Lucas A.D., Chadwick N., Warren B.F., Jewell D.P., Gordon S., Powrie F., et al. The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo. Am J Pathol 158 (2001) 855-866
7. Tacke F., Alvarez D., Kaplan T.J., Jakubzick C., Spanbroek R., Llodra J., et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 117 (2007) 185-194
8. Bazan J.F., Bacon K.B., Hardiman G., Wang W., Soo K., Rossi D., et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 385 (1997) 640-644
9. Ludwig A., Berkhout T., Moores K., Groot P., and Chapman G. Fractalkine is expressed by smooth muscle cells in response to IFN-gamma and TNF-alpha and is modulated by metalloproteinase activity. J Immunol 168 (2002) 604-612
10. Chapman G.A., Moores K.E., Gohil J., Berkhout T.A., Patel L., Green P., et al. The role of fractalkine in the recruitment of monocytes to the endothelium. Eur J Pharmacol 392 (2000) 189-195
11. Imai T., Hieshima K., Haskell C., Baba M., Nagira M., Nishimura M., et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91 (1997) 521-530
12. Landsman L., Bar-On L., Zernecke A., Kim K.W., Krauthgamer R., Shagdarsuren E., et al. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 113 (2009) 963-972
13. McDermott D.H., Fong A.M., Yang Q., Sechler J.M., Cupples L.A., Merrell M.N., et al. Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J Clin Invest 111 (2003) 1241-1250
14. Wasmuth H.E., Zaldivar M.M., Berres M.L., Werth A., Scholten D., Hillebrandt S., et al. The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection. J Hepatol 48 (2008) 208-215
15. Sabate J.M., Ameziane N., Lamoril J., Jouet P., Farmachidi J.P., Soule J.C., et al. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease. Eur J Gastroenterol Hepatol 20 (2008) 748-755
16. Combadiere C., Godin O., Vidal C., Cangialosi A., Proust C., and Tzourio C. Common CX3CR1 alleles are associated with a reduced risk of headaches. Headache 48 (2008) 1061-1066
17. Apostolakis S., Baritaki S., Kochiadakis G.E., Igoumenidis N.E., Panutsopulos D., and Spandidos D.A. Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease. Thromb Res 119 (2007) 63-71
18. McDermott D.H., Halcox J.P., Schenke W.H., Waclawiw M.A., Merrell M.N., Epstein N., et al. Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ Res 89 (2001) 401-407
19. Moatti D., Faure S., Fumeron F., Amara Mel W., Seknadji P., McDermott D.H., et al. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97 (2001) 1925-1928
20. Niessner A., Marculescu R., Haschemi A., Endler G., Zorn G., Weyand C.M., et al. Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation. Thromb Haemost 93 (2005) 949-954
21. Rios D.L., Callegari-Jacques S.M., and Hutz M.H. Endothelial nitric oxide synthase and fractalkine chemokine receptor polymorphisms on angiographically assessed coronary atherosclerosis. Clin Chim Acta 362 (2005) 138-146
22. Winkelmann B.R., Marz W., Boehm B.O., Zotz R., Hager J., Hellstern P., et al. Rationale and design of the LURIC study - a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2 (2001) S1-73
23. Austen W.G., Edwards J.E., Frye R.L., Gensini G.G., Gott V.L., Griffith L.S., et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 51 (1975) 5-40
24. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
25. Wanner C., Horl W.H., Luley C.H., and Wieland H. Effects of HMG-CoA reductase inhibitors in hypercholesterolemic patients on hemodialysis. Kidney Int 39 (1991) 754-760
26. Gugl A., Renner W., Seinost G., Brodmann M., Pabst E., Wascher T.C., et al. Two polymorphisms in the fracalkine receptor CX3CR1 are not associated with peripheral arterial disease. Atherosclerosis 166 (2003) 339-343
27. Nassar B.A., Nanji A.A., Ransom T.P., Rockwood K., Kirkland S.A., Macpherson K., et al. Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors. Scand J Clin Lab Invest 68 (2008) 286-291
28. O'Donnell C.J., Cupples L.A., D'Agostino R.B., Fox C.S., Hoffmann U., Hwang S.J., et al. Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study. BMC Med Genet 8 Suppl. 1 (2007) S4
29. Samani N.J., Erdmann J., Hall A.S., Hengstenberg C., Mangino M., Mayer B., et al. Genomewide association analysis of coronary artery disease. N Engl J Med 357 (2007) 443-453
30. Stark K., Reinhard W., Neureuther K., Wiedmann S., Sedlacek K., Baessler A., et al. Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study. PLoS ONE 3 (2008) e1948
31. Trégouët D.A., König I.R., Erdmann J., Munteanu A., Braund P.S., Hall A.S., et al. Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet 41 (2009) 283-285
32. Erdmann J., Grosshennig A., Braund P.S., König I.R., Hengstenberg C., Hall A.S., et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet 41 (2009) 280-282